Josefa Terrasa

Erlotinib versus standard chemotherapy as first-line treatment for European patients with advanced EGFR mutation-positive non-small-cell lung cancer (EURTAC): a multicentre, open-label, randomised phase 3 trial

Rafael Rosell, Enric Carcereny, Radj Gervais et al. · The Lancet Oncology · 2012 · 5.5K citations · Full text

Medicine, Oncology, Pharmacology +12

Multicenter study evaluating a dual policy of postorchiectomy surveillance and selective adjuvant single-agent carboplatin for patients with clinical stage I seminoma

Jorge Aparicio, Xavier García del Muro, Pablo Maroto et al. · Annals of Oncology · 2003 · 126 citations · Full text

Medicine, Oncology, Surgery +8

Prognostic factors for relapse in stage I seminoma: a new nomogram derived from three consecutive, risk-adapted studies from the Spanish Germ Cell Cancer Group (SGCCG)

Jorge Aparicio, Pablo Maroto, Xavier García del Muro et al. · Annals of Oncology · 2014 · 124 citations · Full text

Medicine, Oncology, Pathology +15

Toxic Epidermal Necrolysis in Patients Receiving Anticonvulsants and Cranial Irradiation: A Risk to Consider

David Aguiar, Roberto Pazo, Ignacio Durán et al. · Journal of Neuro-Oncology · 2004 · 79 citations

Medicine, Neurology, Toxicology +15

SEOM clinical guidelines for the management of germ cell testicular cancer (2016)

Jorge Aparicio, Josefa Terrasa, Ignacio Durán et al. · Clinical & Translational Oncology · 2016 · 26 citations · Full text

Medicine, Oncology, Urology +14